Schedule 13G ownership disclosure

CYCLERION THERAPEUTICS INC

Common Stock, no par value · CUSIP: 23255M204

Event date: 2025-06-30

Filing-level shares
155,187.00
Percent of class
4.8%
  • Tyndall Capital Partners, L.P.

    Shares: 155,187.00 · Class: 4.8%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001641172-25-024017
Form type
SCHEDULE 13G/A
Filer
Korsana Biosciences, Inc.
CIK
CIK 1755237
Filed
Aug 14, 2025
Reporting period
Jun 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub